Life Sciences Tools and Services(IN40214.SH)

AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%

Pharmaron's stock price fell over 3%, with a discount of 8.5% on the placement

Pharmaron opened down 3.37% today, with a low of 23.02 yuan. It is currently reported at 24 yuan, down 3.77%, with a trading volume of 6.4042 million shares, involving 152 million yuan. The company recently announced a placement of nearly 58.4408 million new H shares at a discount of 8.5%, expected to raise nearly 1.32 billion yuan, of which 70% will be used for project construction to enhance laboratory service facilities, drug process development, and production capacity

Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering

Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering

Pharmaron Beijing To Place 58.4 Million New H Shares At RMB1.00 Per Share

Pharmaron Beijing Co Ltd :TO PLACE 58.4 MILLION NEW H SHARES AT RMB1.00 PER SHARE

Pharmaron To Raise HK$1.3 Billion in Share Placement

Pharmaron Beijing Co Ltd :SAYS IT PLANS TO PLACE 58.4 MILLION NEW H-SHARES AT HK$22.82 PER SHARESAYS IT EXPECTS TO RAISE ABOUT HK$1.3 BILLION ($166.74 million) FROM SHARE PLACEMENT TO FUND PROJECT CONSTRUCTION, REPAY BANK LOANS, BOOST CAPITAL($1 = 7.7966 Hong Kong dollars)